The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include minimally invasive surgery for liver metastases in colorectal cancer, expanding clinical trial eligibility criteria for non-small cell lung cancer, and a new targeted therapy for advanced bladder cancer.

In this month’s From the Editor’s Desk, Dr. Schapira reflects on this year’s Advance of the Year and what it says about cancer research more broadly.

Dr. Shilpa Gupta describes the basics of cancer clinical trials, including the possible risks and benefits that they offer.

Lung cancer affects tens of thousands of Americans every year. In this blog post, Cancer.Net Associate Editor Dr. Jyoti Patel describes 9 things every person should know about lung cancer.

In this podcast, Dr. Michael E. Williams reports on the highlights from the 2016 American Society of Hematology Annual Meeting.

In this podcast, Dr. Julie Gralow talks about some of the research highlights from the San Antonio Breast Cancer Symposium.

Cancer affects many people as they grow older, so it’s important to have scientific research that focuses on older adults. Dr. Stuart Lichtman discusses why studies haven’t focused on older adults in the past and what is being done to change that.

The Targeted Agent and Profiling Utilization Registry (TAPUR) study is ASCO’s first clinical trial. In this podcast, ASCO Chief Medical Officer Dr. Richard Schilsky discusses TAPUR and why it is important to patients and the medical community.

Oncology professionals from around the world are in Chicago for the ASCO Annual Meeting. There, they will discuss the latest advances and newest thoughts in cancer research. Today’s highlights cover research that could potentially have the greatest impact to patient care for breast cancer, glioblastoma, neuroblastoma, and multiple myeloma.

Oncology professionals from around the world are in Chicago for the ASCO Annual Meeting. There, they will discuss the latest advances and newest thoughts in cancer research. These studies provide a glimpse into the exciting future of precision medicine.